Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02170Testosterone--
BADD_D02172Testosterone enanthate-
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02176Tetracaine--
BADD_D02179Tetracycline--
BADD_D02180Tetracycline anion--
BADD_D02181Tetracycline hydrochloride--
BADD_D02182Tetradecyl hydrogen sulfate (ester)--
BADD_D02183Tetraethylenepentamine--
BADD_D02187Tetrakis(1-isocyano-2-methoxy-2-methyl-propane)-copper(i) tetrafluoroborate--
BADD_D02188Tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate--
BADD_D02190Tetrofosmin-
BADD_D02192Thalidomide--
BADD_D02195Theophylline--
BADD_D02197Thiamine--
BADD_D02198Thiamine hydrochloride--
BADD_D02203Thiotepa--
BADD_D02204Thiothixene--
BADD_D02208Thyrotropin alfa--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02212Tiaprofenic acid--
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02217Tigecycline--
BADD_D02219Timolol--
BADD_D02221Tinidazole--
BADD_D02222Tinzaparin sodium--
BADD_D02223Tiopronin--
The 40th Page    First    Pre   40 41 42 43 44    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target